Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press releases
  4. Siemens Healthineers introduces Artis icono biplane with detectors specially designed for cardiovascular care
Press release

Siemens Healthineers introduces Artis icono biplane with detectors specially designed for cardiovascular care

Published on 22. Februar 2022

Image Gallery

Siemens Healthineers introduces Artis icono biplane with detectors specially designed for cardiovascular care

Artis icono biplane is Siemens Healthineers’ latest innovation in the field of cardiology, an angiography system with detectors optimized in size for integrated use in the cath lab. The system offers new features for diagnosing and treating cardiac arrhythmia, coronary heart disease, and structural heart disease that simplify clinical workflows and provides excellent image quality at a low radiation dose.
Download Image

Download this press release(pdf, 176.09 KB)
1

within physical limits. 

2

requires syngo Application Software. Cases which can be evaluated with angio-derived FFR are stable coronary syndrome and non-ST elevation acute coronary syndrome.

The statements by customers of Siemens Healthineers described herein are based on results that were achieved in the customer's unique setting. Because there is no “typical” hospital or laboratory and many variables exist (e.g., hospital size, samples mix, case mix, level of IT and/or automation adoption) there can be no guarantee that other customers will achieve the same results.

The products and features mentioned herein are pending 510(k) clearance, and are not yet commercially available in the United States. 

Siemens Healthineers 2022

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2021, which ended on September 30, 2021, Siemens Healthineers, which has approximately 66,000 employees worldwide, generated revenue of €18.0 billion and adjusted EBIT of €3.1 billion. Further information is available at www.siemens-healthineers.com.